H. Yigit, A. M. Queenan, G. J. Anderson, A. Domenech-sanchez, J. W. Biddle et al., Novel Carbapenem-Hydrolyzing ?-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae, Antimicrob Agents Chemother, vol.45, pp.1151-61, 2001.

L. K. Logan and R. A. Weinstein, The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace, J Infect Dis, vol.215, pp.28-36, 2017.

T. Tängdén and C. G. Giske, Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control, J Intern Med, vol.277, pp.501-513, 2015.

A. Lerner, A. Adler, J. Abu-hanna, I. Meitus, S. Navon-venezia et al., Environmental contamination by carbapenem-resistant Enterobacteriaceae, J Clin Microbiol, vol.51, pp.177-81, 2013.
DOI : 10.1128/jcm.01992-12

URL : http://europepmc.org/articles/pmc3536203?pdf=render

F. S. Zimmerman, M. V. Assous, T. Bdolah-abram, T. Lachish, A. M. Yinnon et al., Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge, Am J Infect Control, vol.41, pp.190-194, 2013.

J. Tischendorf, D. Avila, R. A. Safdar, and N. , Risk of infection following colonization with carbapenem-resistant Enterobactericeae: A systematic review, Am J Infect Control, vol.44, pp.539-582, 2016.

Y. Carmeli, M. Akova, G. Cornaglia, G. L. Daikos, J. Garau et al., Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control, Clin Microbiol Infect, vol.16, pp.102-113, 2010.

E. Tacconelli, M. A. Cataldo, S. J. Dancer, D. Angelis, G. Falcone et al., ES-CMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients, Clin Microbiol Infect, vol.20, issue.1, pp.1-55, 2014.

J. Gagnaire, A. Gagneux-brunon, A. Pouvaret, F. Grattard, A. Carricajo et al., Carbapenemase-producing Acinetobacter baumannii : An outbreak report with special highlights on economic burden, Médecine Mal Infect, 2017.

B. Semin-pelletier, L. Cazet, C. Bourigault, M. E. Juvin, D. Boutoille et al., Challenges of controlling a large outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in a French university hospital, J Hosp Infect, vol.89, pp.248-53, 2015.

M. Papadimitriou-olivgeris, M. Marangos, F. Fligou, C. Sklavou, S. Vamvakopoulou et al., KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality, Diagn Microbiol Infect Dis, vol.77, pp.169-73, 2013.

C. Lübbert, N. Lippmann, T. Busch, U. X. Kaisers, T. Ducomble et al., Long-term carriage of Klebsiella pneumoniae carbapenemase-2-producing K pneumoniae after a large single-center outbreak in Germany, Am J Infect Control, vol.42, pp.376-80, 2014.

M. Matt, O. Senard, L. Deconinck, C. Lawrence, A. Dinh et al., État des lieux de la perte de chance liée au cohorting des patients colonisés et/ou infectés à BHRe en secteur dédié de maladies infectieuses

, Med Mal Infect, vol.47, p.32, 2017.

E. Van-nood, A. Vrieze, M. Nieuwdorp, S. Fuentes, E. G. Zoetendal et al., Duodenal infusion of donor feces for recurrent Clostridium difficile, N Engl J Med, vol.368, pp.407-422, 2013.

S. B. Debast, M. P. Bauer, and E. J. Kuijper, European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection, Clin Microbiol Infect, vol.20, pp.1-26, 2014.

M. Hocquart, J. Lagier, N. Cassir, N. Saïdani, C. Eldin et al., Early Faecal Microbiota Transplantation Improves Survival in Severe Clostridium difficile Infections, Clin Infect Dis, vol.66, issue.5, pp.645-50, 2018.

M. Baxter and A. Colville, Adverse events in faecal microbiota transplant: A review of the literature, J Hosp Infect, vol.92, pp.117-144, 2016.

R. Singh, M. Nieuwdorp, I. Ten-berge, F. J. Bemelman, and S. E. Geerlings, The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection, Clin Microbiol Infect, vol.20, pp.1119-1144, 2014.

A. R. Manges, T. S. Steiner, and A. J. Wright, Fecal microbiota transplantation for the intestinal decolonization of extensively antimicrobial-resistant opportunistic pathogens: a review, Infect Dis (Auckl), vol.48, pp.587-92, 2016.

J. C. Lagier, M. Million, P. E. Fournier, P. Brouqui, and D. Raoult, Faecal microbiota transplantation for stool decolonization of OXA-48 carbapenemase-producing Klebsiella pneumoniae, J Hosp Infect, vol.90, pp.173-177, 2015.

B. Davido, R. Batista, H. Michelon, M. Lepainteur, F. Bouchand et al., Is faecal microbiota transplantation an option to eradicate highly drug-resistant enteric bacteria (carbapenem-resistant Enterobacteriaceae and vancomycin-resistant enterococci) carriage, J Hosp Infect, 2017.

J. Bilinski, P. Grzesiowski, N. Sorensen, K. Madry, J. Muszynski et al., Fecal Microbiota Transplantation in Patients with Blood Disorders Inhibits Gut Colonization with Antibiotic-Resistant Bacteria: Results of a Prospective, Clin Infect Dis, vol.65, pp.364-370, 2017.

P. Seng, M. Drancourt, F. Gouriet, L. Scola, B. Fournier et al., Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry, Clin Infect Dis, vol.49, pp.543-51, 2009.

T. D. Lee, K. Adie, A. Mcnabb, D. Purych, K. Mannan et al., Rapid Detection of KPC, NDM, and OXA-48-Like Carbapenemases by Real-Time PCR from Rectal Swab Surveillance Samples, J Clin Microbiol, vol.53, pp.2731-2734, 2015.

, La transplantation de microbiote fécal et son encadrement dans les essais cliniques -Juin 2015 -Actualisation de la version de Mars, (ANSM) L'agence nationale de sécurité du médicament et des produits de santé, 2014.

C. J. Thurlow, K. Prabaker, M. Y. Lin, K. Lolans, R. A. Weinstein et al., Anatomic sites of patient colonization and environmental contamination with Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae at long-term acute care hospitals, Infect Control Hosp Epidemiol, vol.34, pp.56-61, 2013.

E. J. Septimus and L. Schweizer, Decolonization in Prevention of Health Care-Associated Infections, Clin Microbiol, vol.29, pp.201-223, 2016.

R. Sender, S. Fuchs, and R. Milo, Revised Estimates for the Number of Human and Bacteria Cells in the Body, PLoS Biol, vol.14, p.1002533, 2016.

A. M. Stephen and J. H. Cummings, The microbial contribution to human faecal mass, J Med Microbiol, vol.13, pp.45-56, 1980.

B. Fan, J. Guan, X. Wang, and Y. Cong, Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model, PLoS One, vol.11, p.157757, 2016.